跳至主要内容
临床试验/EUCTR2015-000268-32-DE
EUCTR2015-000268-32-DE进行中(未招募)不适用

Prospective, open-label, randomised, single-centre, two-arm, parallel-group, cross-over controlled clinical study, phase 4, to investigate the efficacy of tropicamid 0.5% eyedrops compared to cyclopentolat 0.5% eyedrops for cycloplegia for objective refraction measurement of the eye in 4- to 6-year old children

niversitätsklinikum Erlangen0 个研究点开始时间: 2015年6月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Girls and boys 4 to 6 years of age
  • Indication for objective refraction measurement
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 50
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Other medication within 7 days prior to screening
  • Down syndrome
  • Cerebral lesion in medical history
  • Epilepsy in medical history
  • Severe organic impairment in medical history
  • Mechanical stenosis of the gastro-intestinal tract in medical history

研究者

发起方
niversitätsklinikum Erlangen

相似试验